CasLoc logo
All Cases PTAB Litigations UPC Oppositions

UCB Pharma S.A. v. Nektar Therapeutics

1:20-cv-00650

Overview

Case Number 1:20-cv-00650
Filing Date 2020-05-15
Status Terminated
Termination Date 2021-10-19
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:1338 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Nektar Therapeutics NPE (Individual / Inventor)

Represented By

6 Attorneys Listed

Tiffany Mahmood

Email: tmahmood@goodwinlaw.com

Nicholas K. Mitrokostas

Email: nicholas.mitrokostas@allenovery.com

James Breen

Email: jamesbreen@goodwinlaw.com

Elaine H. Blais

Email: eblais@goodwinlaw.com

Daryl L. Wiesen

Email: dwiesen@goodwinlaw.com

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Plaintiff

Celltech R&D Limited NPE (University / Research)

Represented By

3 Attorneys Listed

Brian P. Egan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9454

1201 North Market Street, P.O. Box 1347

Anthony David Raucci

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9392

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

UCB Pharma S.A. NPE (Individual / Inventor)

Represented By

8 Attorneys Listed

Robert E. Counihan

Email: rcounihan@fenwick.com

Melanie M. Mayer

Email: mmayer@fenwick.com

Kathryn Easterling

Email: keasterling@fenwick.com

James S. Trainor , Jr.

Email: jtrainor@fenwick.com

Catherine H. McCord

Email: cmccord@fenwick.com

Brian P. Egan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9454

1201 North Market Street, P.O. Box 1347

Anthony David Raucci

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9392

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 10 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (10): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7767784
Methods for preparing polymeric reagents and compositions of polymeric reagents
Filed: 2006-07-31
Issued: 2010-08-03
Active (2.4 yrs remaining) +973d PTA
Expires: 2029-03-30
US8193306
Methods for preparing polymeric reagents and compositions of polymeric reagents
Filed: 2010-06-21
Issued: 2012-06-05
Expired (Term Ended)
Expires: 2026-09-09
US8461295
Methods for preparing polymeric reagents and compositions of polymeric reagents
Filed: 2012-05-03
Issued: 2013-06-11
Active (5.5 yrs remaining)
Expires: 2032-05-03
US8809489
Methods for preparing polymeric reagents and compositions of polymeric reagents
Filed: 2013-05-15
Issued: 2014-08-19
Active (6.5 yrs remaining)
Expires: 2033-05-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+973 days) / Cellect Scrutiny — Over 973 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

35

Dispositive

0

Granted

0

Denied

0

Pending / Review

24

Motions by Category

Procedural / Extension Motion 11 Claim Construction / Markman Filing 22 Motion to Compel Discovery 2

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
ORDER STAYING CASE pending resolution of the Arbitration; IT IS FURTHER ORDERED that the claim construction entered by the Court during the June 17, 2021 Markma...
Entry #80 • 2021-06-30 Document →
Claim Construction / Markman Filing Pending
Oral Argument AND Markman Hearing
Entry #— • 2021-06-17
Claim Construction / Markman Filing Pending
Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 6/17/2021, Oral Argument held on 6/17/2021. (Court Reporter V. Gunning...
Entry #— • 2021-06-17
Claim Construction / Markman Filing Pending
ORAL ORDER: IT IS HEREBY ORDERED that, for the reasons articulated by the Court at today's claim construction hearing, the claim term "substantially all of the ...
Entry #— • 2021-06-17
Claim Construction / Markman Filing Pending
ORAL ORDER: The Court will hear oral argument on Defendant's motion to enjoin arbitration (D.I. 30 ) immediately after the Court orally issues its claim constru...
Entry #— • 2021-06-07
Claim Construction / Markman Filing Pending / Under Review
Letter to The Honorable Colm F. Connolly from Anthony D. Raucci regarding Claim Construction Meet and Confer. (Raucci, Anthony) (Entered: 06/03/2021)
Entry #76 • 2021-06-03 Document →

Docket Entries

(147 total)
Procedural / Extension Motion Pending / Under Review

PLAINTIFFS' MOTION FOR LEAVE TO FILE COMPLAINT UNDER SEAL - filed by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # 1 Text of Proposed Order)(myr) (Entered: 05/15/2020)

Entry #1 • 2020-05-15
1
Pleading / Complaint

[SEALED] COMPLAINT filed against Nektar Therapeutics - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2933225.) - filed by UCB Pharma S.A., Celltech R&D Limited. (Attachments: # 1 Exhibit A-H, # 2 Civil Cover Sheet)(myr) (Entered: 05/15/2020)

Entry #2 • 2020-05-15
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) (Entered: 05/15/2020)

Entry #3 • 2020-05-15
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,767,784 B2 ;8,193,306 B2 ;8,461,295 B2 ;8,809,489 B2. (myr) (Entered: 05/15/2020)

Entry #4 • 2020-05-15
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent UCB S.A. and Celltech Group Limited for Celltech R&D Limited, and identifying Corporate Parent UCB S.A. for UCB Pharma S.A. filed by Celltech R&D Limited, UCB Pharma S.A.(myr). (Entered: 05/15/2020)

Entry #5 • 2020-05-15
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc